Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Regulus Therapeutics (RGLS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Watch for Regulus Therapeu to Potentially Pullback After Gaining 7.86% Yesterday

Regulus Therapeu (NASDAQ:RGLS) traded in a range yesterday that spanned from a low of $1.51 to a high of $1.59. Yesterday, the shares gained 7.9%, which took the trading range above the 3-day high of...

RGLS : 1.31 (+2.34%)
Regulus Therapeutics Reports First Quarter 2019 Financial Results and Recent Updates

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today reported financial...

RGLS : 1.31 (+2.34%)
Regulus Therapeutics Announces Closing of First Tranche of $41.8 Million Private Placement of Equity

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today announced the closing of the first tranche...

RGLS : 1.31 (+2.34%)
Regulus Therapeutics Announces Restructuring of Term Loan

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today announced that it has entered into an amendment...

RGLS : 1.31 (+2.34%)
Regulus Therapeutics Announces Private Placement of Equity

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today announced that it has entered into a definitive...

RGLS : 1.31 (+2.34%)
Recent Analysis Shows Regulus Therapeutics, Limbach, CytRx, and Rand Capital Market Influences -- Renewed Outlook, Key Drivers of Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Regulus Therapeutics Inc. (NASDAQ:RGLS),...

LMB : 10.65 (-3.40%)
RAND : 2.81 (-4.75%)
LMBH : 15.6700 (+4.47%)
RGLS : 1.31 (+2.34%)
CYTR : 0.57 (-1.03%)
Regulus to Present Preclinical Efficacy Data Highlighting Potential of Novel Treatment for Nonalcoholic Steatohepatitis at The International Liver Congress(TM) 2019

Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today announced that it will present preclinical...

RGLS : 1.31 (+2.34%)
Regulus Therapeu Set to Possibly Rebound After Yesterday's Selloff of 1.97%

Regulus Therapeu (NASDAQ:RGLS) traded in a range yesterday that spanned from a low of $0.98 to a high of $1.01. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $1.00...

RGLS : 1.31 (+2.34%)
Regulus Reports Fourth Quarter and Year-End 2018 Financial Results and Recent Updates

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today reported financial results for the fourth...

RGLS : 1.31 (+2.34%)
Regulus Announces Transition of Research Leadership

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today announced the resignation of Dr. Timothy...

RGLS : 1.31 (+2.34%)

Van Meerten Stock Picks

Aaon - Pick of the Day
My Stock Pick of the Day is the HVAC company AAON (AAON).
AAON +1.18
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar